Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
Schroers
A
A
Department of Neurology, Neuromuscular Center Ruhrgebiet, Ruhr University, Bochum, Germany.
Kley
R A
RA
Stachon
A
A
Horvath
R
R
Lochmüller
H
H
Zange
J
J
Vorgerd
M
M
D000293:Adolescent; D000328:Adult; D002478:Cells, Cultured; D004734:Energy Metabolism; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D024982:Glycogen Phosphorylase, Muscle Form / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D006012:Glycogen Storage Disease Type V / Q000188:drug therapy* / Q000201:enzymology* / Q000235:genetics; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000201:enzymology; D009154:Mutation; D032446:Myoblasts / Q000187:drug effects / Q000201:enzymology; D009994:Osmolar Concentration; D006005:Phosphorylases / Q000378:metabolism
D005839:Gentamicins; D024982:Glycogen Phosphorylase, Muscle Form; D006005:Phosphorylases